Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-11-045204
Filing Date
2011-09-08
Accepted
2011-09-08 17:54:17
Documents
1
Period of Report
2011-09-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 15739
  Complete submission text file 0001140361-11-045204.txt   17210
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NOVEN PHARMACEUTICALS, INC. 11960 SW 144TH STREET MIAMI FL 33186
Business Address
Brandt Peter C. (Reporting) CIK: 0001434099 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 111081887